<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00508690</url>
  </required_header>
  <id_info>
    <org_study_id>JMTO PREV07-01</org_study_id>
    <secondary_id>UMIN000000776</secondary_id>
    <nct_id>NCT00508690</nct_id>
  </id_info>
  <brief_title>Trial of Antibiotic Prophylaxis in Elective Laparoscopic Colorectal Surgery: Oral and Systemic Versus Systemic Antibiotics</brief_title>
  <official_title>Randomized Controlled Trial of Antibiotic Prophylaxis in Elective Laparoscopic Colorectal Surgery: Oral and Systemic Versus Systemic Antibiotics</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Japan Multinational Trial Organization</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Japan Multinational Trial Organization</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine optimal prophylactic antibiotics administration
      method in elective laparoscopic colorectal surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The use of antibiotic prophylaxis in patients who undergo elective colorectal surgery is now
      accepted universally. But the rout of administration should be systematic, oral, or both is
      controversial. Furthermore, although many trails have been performed, no trial limited to
      laparoscopic surgery is performed. We compare 2 approaches - oral and systemic versus
      systemic antibiotic prophylaxis - in limited to elective laparoscopic colorectal surgery.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2007</start_date>
  <completion_date type="Actual">December 2011</completion_date>
  <primary_completion_date type="Actual">December 2011</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence and classification of surgical site infection (SSI)</measure>
    <time_frame>Within the first 30 days after surgery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of colitis, other infectious diseases and other postoperative complications.</measure>
    <time_frame>Within the first 30 days after surgery</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">584</enrollment>
  <condition>Colorectal Neoplasms</condition>
  <arm_group>
    <arm_group_label>IV</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intravenous dose of 1g cefmetazole just before surgery and additional doses every 3hs during surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Oral/IV</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>2 doses of oral kanamycin(1g)/ metronidazole(750mg) administration on the day before surgery with intravenous dose of 1g cefmetazole just before surgery and additional doses every 3hs during surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>cefmetazole</intervention_name>
    <description>Intravenous dose of 1g cefmetazole just before surgery and additional doses every 3hs during surgery</description>
    <arm_group_label>IV</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>kanamycin/metronidazole</intervention_name>
    <description>2 doses of oral kanamycin(1g)/ metronidazole(750mg) administration on the day before surgery with intravenous dose of 1g cefmetazole just before surgery and additional doses every 3hs during surgery</description>
    <arm_group_label>Oral/IV</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Colorectal tumor(cancer, adenoma and suspected cases) with planned elective
             laparoscopic colorectal resection

        Exclusion Criteria:

          -  ECOG Performance Status &gt;=2

          -  Age&lt;20

          -  Any organ dysfunction

          -  Ileus

          -  Preoperative infectious disease

          -  Antibiotic administration before surgery

          -  Steroid administration before surgery

          -  Neo-adjuvant radiation and/or chemo therapy

          -  Severe diabetes mellitus

          -  Pregnancy/lactational woman

          -  Severe allergy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hiroaki Hata, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Hospital Organization Kyoto Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Tenriyorozu Hospital</name>
      <address>
        <city>Tenri</city>
        <state>Nara</state>
        <zip>6328552</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kyoto Univercity Hospital</name>
      <address>
        <city>Kyoto</city>
        <zip>606-8507</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National Hospital Organization, Kyoto Medical Center</name>
      <address>
        <city>Kyoto</city>
        <zip>612-8555</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kyoto Katsura Hospital</name>
      <address>
        <city>Kyoto</city>
        <zip>6158256</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kitano Hospital</name>
      <address>
        <city>Osaka</city>
        <zip>5308480</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Japan</country>
  </location_countries>
  <link>
    <url>http://www.umin.ac.jp/ctr/index.htm</url>
    <description>UMIN Clinical Trial Registry: Unique trial number UMIN000000776</description>
  </link>
  <verification_date>September 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 27, 2007</study_first_submitted>
  <study_first_submitted_qc>July 27, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 30, 2007</study_first_posted>
  <last_update_submitted>September 18, 2012</last_update_submitted>
  <last_update_submitted_qc>September 18, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 19, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Japan Multinational Trial Organization</investigator_affiliation>
    <investigator_full_name>Hiroaki Hata</investigator_full_name>
    <investigator_title>member</investigator_title>
  </responsible_party>
  <keyword>Antibiotic Prophylaxis</keyword>
  <keyword>Colorectal Surgery</keyword>
  <keyword>Laparoscopy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colorectal Neoplasms</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anti-Bacterial Agents</mesh_term>
    <mesh_term>Kanamycin</mesh_term>
    <mesh_term>Cefmetazole</mesh_term>
    <mesh_term>Antibiotics, Antitubercular</mesh_term>
    <mesh_term>Metronidazole</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

